Ian Karp
Head of Investor Relations
Replay available
Collegium Pharmaceutical, Inc. (COLL) Q2 2026 Earnings Call
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) Q2 2026 earnings conference call, held 2026-08-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Vikram Karnani
President and Chief Executive Officer
Colleen Tupper
Chief Financial Officer
Serge Belander
Analyst, Needham & Co.
Dennis Ding
Analyst, Jefferies
Brandon Fulks
Analyst, HC Wainwright
Alex von Reisman
Analyst, Piper Sandler
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Collegium Pharmaceutical, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.073 Greetings and welcome to the Collegium Pharmaceutical Second Quarter 2026 Earnings 00:00:05.073 -- 00:00:10.294 Conference Call. At this time, all participants are in a listen-only mode. 00:00:10.294 -- 00:00:13.895 A question and answer session will follow the formal presentation. 00:00:13.895 -- 00:00:18.337 If anyone should require operator assistance during this conference call, please press 00:00:18.337 -- 00:00:23.618 star zero on your telephone keypad. Please note that this conference call is being recorded. 00:00:23.618 -- 00:00:27.640 I will now like to turn the call over to Ian Karp, Head of Investor Relations. 00:00:27.640 -- 00:00:30.740 Thank you. You may begin. 00:00:30.780 -- 00:00:35.002 Great, thanks so much, and welcome to Collegium Pharmaceutical's second quarter 2026 00:00:35.002 -- 00:00:39.825 earnings conference call. I'm joined today by Vikram Karnani, our president and chief 00:00:39.825 -- 00:00:43.728 executive officer, and Colleen Tupper, our chief financial officer. 00:00:43.728 -- 00:00:47.490 Before we begin today's call, we want to remind participants that none of the information 00:00:47.490 -- 00:00:51.612 presented today is intended to be promotional and that any forward-looking statements 00:00:51.612 -- 00:00:56.395 made today are made pursuant to the safe harbor provision of the Private Securities Litigation 00:00:56.395 -- 00:00:58.678 Reform Act of 1995. 00:00:58.678 -- 00:01:02.381 We are cautioned that such forward-looking statements involve risks and uncertainties 00:01:02.381 -- 00:01:06.223 as detailed in the company's periodic reports filed with the Securities and Exchange 00:01:06.223 -- 00:01:11.287 Commission. Our future results may differ materially from our current expectations dis...